Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro

L. Navrátilová, J. Ramos Mandíková, P. Pávek, P. Mladěnka, F. Trejtnar,

. 2018 ; 48 (7) : 745-755. [pub] 20170818

Language English Country England, Great Britain

Document type Journal Article

1. Some flavonoids contained in the common diet have been shown to interact with important membrane uptake transporters, including organic anion transporting polypeptides (OATPs). OATP2B1 and OATP1A2 expressed in the apical membrane of human enterocytes may significantly contribute to the intestinal absorption of drugs, e.g. statins. This study is aimed at an evaluation of the inhibitory potency of selected food honey flavonoids (namely galangin, myricetin, pinocembrin, pinobanksin, chrysin and fisetin) toward hOATP2B1 and hOATP1A2 as well as at examining their effect on the cellular uptake of the known OATP substrate rosuvastatin. 2. Cell lines overexpressing the hOATP2B1 or hOATP1A2 transporter were employed as in vitro model to determine the inhibitory potency of the flavonoids toward the OATPs. 3. Chrysin, galangin and pinocembrin were found to inhibit both hOATP2B1 and hOATP1A2 in lower or comparable concentrations as the known flavonoid OATP inhibitor quercetin. Galangin, chrysin and pinocembrin effectively inhibited rosuvastatin uptake by hOATP2B1 with IC50 ∼1-10 μM. The inhibition of the hOATP1A2-mediated transport of rosuvastatin by these flavonoids was weaker. 4. The found data indicate that several of the tested natural compounds could potentially affect drug cellular uptake by hOATP2B1 and/or hOATP1A2 at relative low concentrations, a finding which suggests their potential for food-drug interactions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033808
003      
CZ-PrNML
005      
20181012111031.0
007      
ta
008      
181008s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/00498254.2017.1358469 $2 doi
035    __
$a (PubMed)28745105
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Navrátilová, Lucie $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
245    10
$a Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro / $c L. Navrátilová, J. Ramos Mandíková, P. Pávek, P. Mladěnka, F. Trejtnar,
520    9_
$a 1. Some flavonoids contained in the common diet have been shown to interact with important membrane uptake transporters, including organic anion transporting polypeptides (OATPs). OATP2B1 and OATP1A2 expressed in the apical membrane of human enterocytes may significantly contribute to the intestinal absorption of drugs, e.g. statins. This study is aimed at an evaluation of the inhibitory potency of selected food honey flavonoids (namely galangin, myricetin, pinocembrin, pinobanksin, chrysin and fisetin) toward hOATP2B1 and hOATP1A2 as well as at examining their effect on the cellular uptake of the known OATP substrate rosuvastatin. 2. Cell lines overexpressing the hOATP2B1 or hOATP1A2 transporter were employed as in vitro model to determine the inhibitory potency of the flavonoids toward the OATPs. 3. Chrysin, galangin and pinocembrin were found to inhibit both hOATP2B1 and hOATP1A2 in lower or comparable concentrations as the known flavonoid OATP inhibitor quercetin. Galangin, chrysin and pinocembrin effectively inhibited rosuvastatin uptake by hOATP2B1 with IC50 ∼1-10 μM. The inhibition of the hOATP1A2-mediated transport of rosuvastatin by these flavonoids was weaker. 4. The found data indicate that several of the tested natural compounds could potentially affect drug cellular uptake by hOATP2B1 and/or hOATP1A2 at relative low concentrations, a finding which suggests their potential for food-drug interactions.
650    _2
$a zvířata $7 D000818
650    _2
$a dieta $7 D004032
650    _2
$a psi $7 D004285
650    _2
$a flavonoidy $x farmakologie $7 D005419
650    _2
$a HEK293 buňky $7 D057809
650    12
$a med $7 D006722
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a buňky MDCK $7 D061985
650    _2
$a biologické modely $7 D008954
650    _2
$a přenašeče organických aniontů $x antagonisté a inhibitory $x metabolismus $7 D027361
650    _2
$a transport proteinů $x účinky léků $7 D021381
650    _2
$a rosuvastatin kalcium $x metabolismus $7 D000068718
650    _2
$a transfekce $7 D014162
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ramos Mandíková, Jana $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
700    1_
$a Pávek, Petr $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
700    1_
$a Mladěnka, Přemysl $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
700    1_
$a Trejtnar, František $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
773    0_
$w MED00004746 $t Xenobiotica; the fate of foreign compounds in biological systems $x 1366-5928 $g Roč. 48, č. 7 (2018), s. 745-755
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28745105 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181012111523 $b ABA008
999    __
$a ok $b bmc $g 1340306 $s 1030802
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 48 $c 7 $d 745-755 $e 20170818 $i 1366-5928 $m Xenobiotica $n Xenobiotica $x MED00004746
LZP    __
$a Pubmed-20181008

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...